Edward P. Armstrong

Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation

Amanda Harrington, Edward P. Armstrong, Paul E. Nolan et al. · Stroke · 2013 · 258 citations

Concordance of Severity Ratings Provided in Four Drug Interaction Compendia

Jacob Abarca, Daniel C. Malone, Edward P. Armstrong et al. · Journal of the American Pharmacists Association · 2004 · 207 citations

Drug Safety, Drug Interactions, Substance Abuse +11

Acute Exacerbations of COPD in the United States: Inpatient Burden and Predictors of Costs and Mortality

Prasadini Perera, Edward P. Armstrong, Duane L. Sherrill et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 2012 · 204 citations · Full text

Pulmonary Care, Advanced Lung Disease, Inpatient Burden +20

Identification of Serious Drug–Drug Interactions: Results of the Partnership to Prevent Drug–Drug Interactions

Daniel C. Malone, Edward P. Armstrong, Jacob Abarca et al. · Journal of the American Pharmacists Association · 2004 · 189 citations

Drug Interactions, Substance Abuse, Prevent Drug–drug Interactions +8

Clinical and Economic Analysis of Methicillin-Susceptible and -Resistant <i>Staphylococcus aureus</i> Infections

Brian J. Kopp, David E. Nix, Edward P. Armstrong · Annals of Pharmacotherapy · 2004 · 138 citations